Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients

被引:9
|
作者
Pellegrino, Marsha [1 ]
Traversi, Gianandrea [1 ]
Arena, Andrea [1 ]
Cappa, Marco [2 ]
Rosado, M. Manuela [3 ]
Andreani, Marco [4 ]
Delfino, Domenico, V [5 ]
Moretti, Fabiola [6 ]
Fierabracci, Alessandra [1 ]
机构
[1] Bambino Gesu Pediat Hosp, Infectivol & Clin Trials Res Dept, IRCCS, Rome, Italy
[2] Bambino Gesu Pediat Hosp, Endocrinol Dept, IRCCS, Rome, Italy
[3] Bambino Gesu Pediat Hosp, IRCCS, Res Labs, Rome, Italy
[4] Bambino Gesu Pediat Hosp, IRCCS, Transplantat Immunogenet Lab, Rome, Italy
[5] Univ Perugia, Dept Med, Sect Pharmacol, Perugia, Italy
[6] Natl Res Council Italy CNR, Inst Cell Biol & Neurobiol, Rome, Italy
来源
PLOS ONE | 2020年 / 15卷 / 01期
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-SUPPRESSOR GENE; AUTOIMMUNE-DISEASES; ARTHRITIS; POLYMORPHISM; EXPRESSION; ANTIBODIES; MUTATIONS; TP53; MDM2;
D O I
10.1371/journal.pone.0228296
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Various immunotherapies for the treatment of type 1 diabetes are currently under investigation. Some of these aim to rescue the remaining beta cells from autoimmune attack caused by the disease. Among the strategies employed, p53 has been envisaged as a possible target for immunomodulation. We studied the possible effect of p53 activation on Treg subsets and Treg/Teff balance in type 1 diabetes patients' PBMC. Upon p53 activation, we observed an increase in CD8+ Treg and activated CD8+ Teff whilst CD8+ Teff cells significantly decreased in healthy PBMC when stimulated with anti-CD3/CD28. No effect was detected on percentages of CD4+ Treg, while a reduction was seen in CD4+ Teff cells and an increase in activated CD4+ Teff cells. In patients' PBMC, upon p53 activation followed by 6 days of anti-CD3/CD28 stimulation, CD8+ Treg and activated CD8+ Teff were increased while CD8+ Teff were decreased. No differences were detected in the CD4+ counterparts. CD8+ Teff PD1+, CD8+ Teff PD1low were increased upon p53 activation in type 1 diabetics compared to controls while CD8+ Teff PD1high were increased in both groups. The same increased percentages were detected for CD4+ counterparts. CD4+ Treg PD1high cells were decreased in diabetics upon p53 activation at day 6 of anti-CD3/CD28 stimulation. In conclusion, a Teff dysregulation is observed upon p53 activation suggesting that molecules promoting p53 cannot be used for therapy in type 1 diabetics.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] Reactivation of p53 signaling in hepatoblastoma with a stapled peptide dual inhibitor of MDM2 and MDM4
    Woodfield, Sarah E.
    Patel, Roma H.
    Ibarra, Aryana M.
    Chen, Zhenghu
    Vasudevan, Sanjeev A.
    CANCER RESEARCH, 2018, 78 (19)
  • [22] Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development
    Xiong, SB
    Van Pelt, CS
    Elizondo-Fraire, AC
    Liu, G
    Lozano, G
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (09) : 3226 - 3231
  • [23] Expression of MDM2, MDM4 and p53 and Association with Outcome in 162 Cases of Gastric Adenocarcinoma
    Rock, J. B.
    Hatzaras, I. S.
    Suarez, A. A.
    Zhou, X.
    Bloomston, M. P.
    Frankel, W. L.
    MODERN PATHOLOGY, 2011, 24 : 166A - 166A
  • [24] Conservation of all three p53 family members and Mdm2 and Mdm4 in the cartilaginous fish
    Lane, David P.
    Madhumalar, Arumugam
    Lee, Alison P.
    Tay, Boon-Hui
    Verma, Chandra
    Brenner, Sydney
    Venkatesh, Byrappa
    CELL CYCLE, 2011, 10 (24) : 4272 - 4279
  • [25] Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish
    J S Chua
    H P Liew
    L Guo
    D P Lane
    Oncogene, 2015, 34 : 5933 - 5941
  • [26] Expression of MDM2, MDM4 and p53 and Association with Outcome in 162 Cases of Gastric Adenocarcinoma.
    Rock, J. B.
    Hatzaras, I. S.
    Suarez, A. A.
    Zhou, X.
    Bloomston, M. P.
    Frankel, W. L.
    LABORATORY INVESTIGATION, 2011, 91 : 166A - 166A
  • [27] Simultaneous measurement of p53:Mdm2 and p53:Mdm4 protein-protein interactions in whole cells using fluorescence labelled foci
    Frosi, Y.
    Inoue, K.
    Ramlan, Siti Radhiah
    Lane, D. P.
    Watanabe, T.
    Brown, C. J.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [28] Alternatively spliced forms orf the p53 modulators MDM2 and MDM4 are prevalent in pediatric rhabdomyosarcomas
    O'Brien, Dennis M.
    Chandler, Dawn S.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 609 - 609
  • [29] Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4
    Chandler, Dawn S.
    Singh, Ravi K.
    Caldwell, Lisa C.
    Bitler, Jaquelyn L.
    Lozan, Guillermina
    CANCER RESEARCH, 2006, 66 (19) : 9502 - 9508
  • [30] Tumor-specific signaling to p53 is mimicked by Mdm2 inactivation in zebrafish: insights from mdm2 and mdm4 mutant zebrafish
    Chua, J. S.
    Liew, H. P.
    Guo, L.
    Lane, D. P.
    ONCOGENE, 2015, 34 (48) : 5933 - 5941